Disease on EC 1.14.17.1 - dopamine beta-monooxygenase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Abortion, Spontaneous
[Activity of the adrenergic nervous system in the pathophysiology of pregnancy and labor. III. Plasma dopamine beta-hydroxylase activity in women during spontaneous abortion]
Acidosis
Endothelin-1/endothelin-B receptor-mediated increases in NHE3 activity in chronic metabolic acidosis.
Acute Kidney Injury
Total kininogen levels, plasma renin activity, dopamine-beta-hydroxylase and plasma catecholamines in chronic and acute renal failure.
Alcohol Withdrawal Delirium
A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function.
[Combination of DAT and DBH gene polymorphisms with a family history of alcohol use disorders increases the risk of withdrawal seizures and delirium tremens during alcohol withdrawal in alcohol-dependent men].
Alcohol Withdrawal Seizures
Disulfiram-Induced De Novo Convulsions without Alcohol Challenge: Case Series and Review of Literature.
Alkalosis
Reevaluation of the disulfiram-alcohol reaction in man.
Altitude Sickness
Influence of age, sex and hypoxia on plasma dopamine-beta-hydroxylase activity in the rat.
Alzheimer Disease
Association of Dopamine Beta-Hydroxylase Polymorphisms with Alzheimer's Disease, Parkinson's Disease and Schizophrenia: Evidence Based on Currently Available Loci.
Dopamine-beta-hydroxylase and acetylcholinesterase activities of cerebrospinal fluid in Alzheimer's disease.
Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease.
Increased lymphocyte dopamine beta-hydroxylase immunoreactivity in Alzheimer's disease: compensatory response to cholinergic deficit?
Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk.
Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type.
Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.
Noradrenergic innervation of human pineal gland: abnormalities in aging and Alzheimer's disease.
Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease.
Amebiasis
Neurohumoral alterations and their role in amoebiasis.
Amnesia
Clonidine reverses the amnesia induced by dopamine beta hydroxylase inhibition.
Role of the biogenic amines in the reversal of cycloheximide-induced amnesia.
Some characteristics of amnesia induced by FLA-63 an inhibitor of dopamine beta hydroxylase.
Amyloid Neuropathies, Familial
Autonomic involvement in inherited neuropathies.
Catecholamine metabolism in familial amyloid polyneuropathy.
The discovery of the pressor effect of DOPS and its blunting by decarboxylase inhibitors.
Amyloidosis
Bilateral Horner's syndrome: detection and occurrence.
Pupil abnormalities in selected autonomic neuropathies.
Anemia
Genomic organization of ATOX1, a human copper chaperone.
[Familial juvenile parkinsonism with dementia and autonomic failure--a case report]
Angina Pectoris
Serum dopamine beta-hydroxylase in cardiovascular diseases.
[Proceedings: Serum dopamine beta-hydroxylase activities and electrocardiographic changes in cases with symptoms characteristic of angina pectoris]
Aortic Coarctation
Changes in plasma catecholamines and dopamine beta-hydroxylase after corrective surgery for coarctation of the aorta.
Asthma, Exercise-Induced
Serum dopamine beta-hydroxylase and free fatty acids in exercise-induced asthma.
Autonomic Dysreflexia
Autonomic hyperreflexia and its differentiation from pheochromocytoma.
Bradycardia
Metabolic and endocrine changes in spinal cord injury: II (section 1). Consequences of partial decentralization of the autonomic nervous system.
Brain Diseases
Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism.
Schizophrenia: dopamine beta-hydroxylase activity and treatment response.
[Disulfiram (Esperal) toxicity. Apropos of 3 original cases]
Brain Injuries, Traumatic
Tyrosine hydroxylase, but not dopamine beta-hydroxylase, is increased in rat frontal cortex after traumatic brain injury.
Bruxism
Experimental aggression and bruxism in rats.
Carcinoid Tumor
Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomas.
Carcinoma
Serotonin and 5-hydroxyindoleacetic acid are increased in the sigmoid colon in severe idiopathic constipation.
Studies on marine microorganisms. IV. A new antibiotic SS-228 Y produced by Chainia isolated from shallow sea mud.
The human prostate gland: a histochemical and immunohistochemical study of neuropeptides, serotonin, dopamine beta-hydroxylase and acetylcholinesterase in autonomic nerves and ganglia.
Carcinoma, Hepatocellular
Letter: Serum dopamine-beta-hydroxylase activity in patients with leukemia and in patients with hepatoma.
Cardiomegaly
Sympathetic {alpha}2-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload.
Cardiovascular Diseases
Determination of Dopamine-?-hydroxylase Activity in Human Serum Using UHPLC-PDA Detection.
Serum dopamine beta-hydroxylase in cardiovascular diseases.
Cataract
Dopamine-beta-hydroxylase activity in plasma, spleen and adrenal gland of streptozotocin-diabetic rats: correlation with cataracts.
Cerebral Hemorrhage
[Changes in plasma dopamine-beta-hydroxylase activity in patients with acute intracerebral hemorrhage (author's transl)]
Cerebrovascular Disorders
Serum dopamine-beta-hydroxylase activity in acute stroke.
Cholera
The pontine A5 noradrenergic cells which project to the spinal cord dorsal horn are reciprocally connected with the caudal ventrolateral medulla in the rat.
The ventrolateral medulla of the rat is connected with the spinal cord dorsal horn by an indirect descending pathway relayed in the A5 noradrenergic cell group.
Chorea
[Dopamine beta hydroxylase. Value and limits of its study in neurology]
Coma
Changes in serum dopamine beta hydroxylase activity related to coma.
Coronary Artery Disease
Assessment of myocardial sympathetic activity in coronary heart disease.
Coronary Disease
Lack of correlation between serum dopamine-beta-hydroxylase activity and blood pressure in middle-aged men.
[Dopamine beta-hydroxylase activity in various types of coronary disease]
Craniocerebral Trauma
Circulating catecholamines and sympathetic activity after head injury.
Cystic Fibrosis
Dopamine-beta-hydroxylase in patients with cystic fibrosis.
Electrolytes and norepinephrine levels in blood of patients with cystic fibrosis.
Plasma and urinary catecholamines in patients with cystic fibrosis.
Delirium
Biochemical investigations into the alcoholic delirium: alterations of biogenic amines.
[Biochemical studies in delirium tremens (author's transl)]
Dementia
Dopamine-beta-hydroxylase and acetylcholinesterase activities of cerebrospinal fluid in Alzheimer's disease.
Neurotransmitters in dementia.
Platelet monoamine oxidase, plasma dopamine beta-hydroxylase activity, dementia and family history of alcoholism in chronic alcoholics.
Diabetes Complications
Dopamine-beta-hydroxylase activity in plasma, spleen and adrenal gland of streptozotocin-diabetic rats: correlation with cataracts.
Diabetes Insipidus
Elevated serum dopamine-beta-hydroxylase activity in rats with inherited diabetes insipidus.
Diabetes Mellitus
Circulating dopamine-beta-hydroxylase in the rat: importance of altered disposal pathways in experimental diabetes.
Relationship between the activity of plasma dopamine-beta-hydroxylase and the duration of diabetes mellitus.
[Dopamine beta-hydroxylase activity in diabetes mellitus]
Diabetes Mellitus, Experimental
Identification of dystrophic sympathetic axons in experimental diabetic autonomic neuropathy.
Orthograde and retrograde axonal transport of dopamine-beta-hydroxylase in ileal mesenteric nerves of rats with chronic streptozotocin diabetes.
Diabetes, Gestational
[Activity of plasma dopamine-beta-hydroxylase in newborn infants. Implication in prematurity, maternal pathology and growth]
Diabetic Neuropathies
A study of the possible relationship of serum dopamine-beta-hydroxylase activity with diabetic neuropathy.
Bilateral Horner's syndrome: detection and occurrence.
Effects of chronic experimental streptozotocin-induced diabetes on the noradrenergic and peptidergic innervation of the rat alimentary tract.
dopamine beta-monooxygenase deficiency
Abnormal cardiovascular and catecholamine responses to supine exercise in human subjects with sympathetic dysfunction.
Abnormalities of the QT interval in primary disorders of autonomic failure.
Autonomic involvement in inherited neuropathies.
Bilateral Horner's syndrome: detection and occurrence.
Chronic hypotension. In the shadow of hypertension.
Congenital dopamine beta-hydroxylase deficiency.
Congenital dopamine-beta-hydroxylase deficiency in humans.
Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome.
D,L-threo-3, 4-DOPS enhances rapid eye movement sleep in patients with congenital dopamine beta-hydroxylase deficiency.
d,l-threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency.
DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa.
Determination of D,L-threo-3,4-dihydroxyphenylserine and of the D- and L-enantiomers in human plasma and urine.
Dopamine beta-hydroxylase deficiency associated with mutations in a copper transporter gene.
Dopamine beta-hydroxylase deficiency impairs cellular immunity.
Dopamine beta-hydroxylase deficiency involves the central autonomic network.
Dopamine beta-hydroxylase deficiency.
Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation.
Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency.
Dopamine in dopamine-beta-hydroxylase deficiency.
Dopamine-beta-hydroxylase deficiency in humans.
Dopamine-beta-hydroxylase: a modulator of beta adrenergic receptor activity.
Droxidopa for Hypotension of Different Etiologies: Two Case Reports.
Droxidopa for Symptomatic Neurogenic Hypotension.
Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in dopamine-beta-hydroxylase deficiency.
Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency.
Genetic determinants of dopaminergic activity: potential role in blood pressure regulation.
Genomic organization of ATOX1, a human copper chaperone.
Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.
Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.
L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.
Liquid-chromatographic determination of free and total 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol in urine.
Patients with congenital dopamine beta-hydroxylase deficiency. A lesson in catecholamine physiology.
Peripartum management of a patient with dopamine beta-hydroxylase deficiency, a rare congenital cause of dysautonomia.
Pupil abnormalities in selected autonomic neuropathies.
Reflex control of sympathetic nerve activity in dopamine beta-hydroxylase deficiency.
Role of sympathetic efferent nerves in blood pressure regulation and in hypertension.
Sleep patterns in congenital dopamine beta-hydroxylase deficiency.
Sleeping with and without norepinephrine: effects of metoclopramide and D,L-threo-3,4-dihydroxyphenylserine on sleep in dopamine beta-hydroxylase deficiency.
The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine.
The expression of PHOX2A, PHOX2B and of their target gene dopamine-beta-hydroxylase (DbetaH) is not modified by exposure to extremely-low-frequency electromagnetic field (ELF-EMF) in a human neuronal model.
The pathophysiology and diagnosis of orthostatic hypotension.
The role of clinical pharmacology in molecular genetics.
The sympathetic skin response in peripheral autonomic failure--evaluation in pure failure, pure cholinergic dysautonomia and dopamine-beta-hydroxylase deficiency.
Total norepinephrine spillover, muscle sympathetic nerve activity and heart-rate spectral analysis in a patient with dopamine beta-hydroxylase deficiency.
[Etiological aspects of orthostatic hypotension]
[From gene to disease; dopamine-beta-hydroxylase deficiency and orthostatic hypotension]
Down Syndrome
Low dopamine-beta-hydroxylase activity in Down's syndrome.
Serum dopamine-beta-hydroxylase activity in Down's syndrome: a familial study.
Serum dopamine-beta-hydroxylase levels in Down's syndrome.
Dysautonomia, Familial
Bilateral Horner's syndrome: detection and occurrence.
Pupil abnormalities in selected autonomic neuropathies.
Serum dopamine-beta-hydroxylase in familial dysautonomia.
Dyskinesias
A biochemical study of tardive dyskinesia in young male patients.
Enzyme studies in tardive dyskinesia. I. One-year biochemical follow-up.
Multivariate analysis of monoamine indices in patients with chronic schizophrenia.
[Serum dopamine-beta-hydroxylase, glutamic acid decarboxylase and 1-aromatic amino acid decarboxylase in involuntary movement disorders (author's transl)]
Dystonia
Dopamine beta-hydroxylase gene excluded in four subtypes of hereditary dystonia.
Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34.
Human gene for torsion dystonia located on chromosome 9q32-q34.
Plasma norepinephrine and dopamine-beta-hydroxylase in dystonia.
The pathophysiology of dystonia.
Dystonia Musculorum Deformans
A familial study in serum dopamine-beta-hydroxylase levels in torsion dystonia.
Dopamine beta-hydroxylase activity in cerebrospinal fluid of idiopathic torsion dystonia.
Dopamine-beta-hydroxylase (DBH) in idiopathic torsion dystonia (ITD).
Dystonia in 61-year-old identical twins: observations over 45 years.
Genome-wide scan for Parkinson's disease: the GenePD Study.
Serum dopamine beta hydroxylase activity and metoclopramide provocative test in torsion dystonia.
The pathophysiology of dystonia.
[Dopamine beta hydroxylase. Value and limits of its study in neurology]
Dystonic Disorders
Dopamine beta-hydroxylase gene excluded in four subtypes of hereditary dystonia.
Endocrine System Diseases
[Etiological aspects of orthostatic hypotension]
[Serum dopamine-beta-hydroxylase activity in endocrine disease and hypertension (author's transl)]
Epilepsy
Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura.
Human circulating dopamine-beta-hydroxylase and epilepsy.
New genetic evidence for involvement of the dopamine system in migraine with aura.
Essential Hypertension
A comparison of catecholamine concentrations and dopamine-beta-hydroxylase activities in plasma from normotensive subjects and from patients with essential hypertension at rest and during exercise.
Dopamine beta-hydroxylase and plasma renin activity in patients with low-, normal-, and high-renin essential hypertension.
Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency.
Dopamine-beta-hydroxylase activity and catecholamine concentrations in plasma: experimental and essential hypertension.
Effect of clonidine on sympathetic nervous system activity in patients with essential hypertension.
Effects of various stimuli on plasma dopamine beta-hydroxylase activity in essential hypertension with respect to aging and hypertension severity index.
Interrelations between plasma renin activity, aldosterone, and sympathetic nervous system activity in essential hypertension.
Plasma dopamine-beta-hydroxylase activity and blood pressure variability in hypertensive man.
Renal and systemic hemodynamics in sustained essential hypertension.
Serum dopamine beta-hydroxylase activity in essential hypertension.
Serum dopamine beta-hydroxylase in cardiovascular diseases.
Serum dopamine-beta-hydroxylase activity in essential hypertension and in chronic renal failure with hypertension.
Studies on the role of sympathetic nervous system in the mechanism of essential hypertension.
The meaning of dopamine beta-hydroxylase in essential hypertension.
The role of serum dopamine-beta-hydroxylase in essential hypertension.
[Activity of dopamine beta-hydroxylase in the serum of patients with essential hypertension]
[Dopamine-beta-hydroxylase activity and catecholamine concentration in plasma as a parameter of sympathetic tonus: effect of the ergometric test on patients with normotension and essential hypertension]
[Dopamine-beta-hydroxylase activity, aldosterone level, and plasma renin activity in patients with essential hypertension during exposure to physical load (author's transl)]
[Essential hypertension and dopamine beta-hydroxylase]
[Study on Dopamine-beta-hydroxylase activity in serum in patients with essential hypertension at rest and during exercise (author's transl)]
Essential Tremor
Brain biochemistry in autopsied patients with essential tremor.
Fabry Disease
Autonomic involvement in inherited neuropathies.
Bilateral Horner's syndrome: detection and occurrence.
Familial Mediterranean Fever
Dopamine-beta-hydroxylase activity in familial Mediterranean fever.
Plasma dopamine beta-hydroxylase activity in familial Mediterranean fever.
Fetal Death
Neurotransmitters and neuromodulators during early human development.
Fetal Growth Retardation
The study of levels of norepinephrine and dopamine-beta-hydroxylase in patients with pregnancy-induced hypertension.
Ganglioglioma
A clinicopathologic and immunomorphologic study of 13 cases of ganglioglioma.
Ganglioneuroma
Concomitant occurrence of an adrenal ganglioneuroma and a contralateral pheochromocytoma in a patient with von Recklinghausen's neurofibromatosis. An immunocytochemical study.
Genetic Diseases, Inborn
Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation.
Glioblastoma
Mouse cytochrome b561: cDNA cloning and expression in rat brain, mouse embryos, and human glioma cell lines.
Glioma
Dopamine-beta-hydroxylase activity in cholinergic neuroblastoma times glioma hybrid cells; increase of activity by N6,O2'-dibutyryl adenosine 3':5'-cyclic monophosphate.
Graves Disease
Effect of beta-adrenergic blockade on plasma dopamine-beta-hydroxylase activity and triiodothyronine in hyperthyroidism.
Plasma dopamine-beta-hydroxylase activity and thyroid suppressibility in Graves' disease.
Heart Diseases
Auricular tyrosine hydroxylase and dopamine-beta-hydroxylase activities and noradrenaline content in ischaemic heart disease.
Myocardial catecholamines and their biosynthetic enzymes in various human heart diseases.
Serum dopamine beta-hydroxylase activity in acute cardiac disease.
Heart Failure
Auricular tyrosine hydroxylase and dopamine-beta-hydroxylase activities and noradrenaline content in ischaemic heart disease.
Catecholamine metabolism in patients with congestive heart failure under acute and chronic oral levodopa therapy.
Dopamine-beta-hydroxylase inhibition: a novel sympatho-modulatory approach for the treatment of congestive heart failure.
Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.
Low serum dopamine beta-hydroxylase activity. A marker of congestive heart failure.
Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics.
Plasma norepinephrine concentration and plasma dopamine-beta-hydroxylase activity in patients with congestive heart failure.
Serum dopamine beta-hydroxylase in cardiovascular diseases.
Heart Septal Defects, Atrial
Auricular tyrosine hydroxylase and dopamine-beta-hydroxylase activities and noradrenaline content in ischaemic heart disease.
Heart Valve Diseases
Auricular tyrosine hydroxylase and dopamine-beta-hydroxylase activities and noradrenaline content in ischaemic heart disease.
Hepatic Encephalopathy
Neurotransmitter modifications in human cerebrospinal fluid and serum during hepatic encephalopathy.
Hepatolenticular Degeneration
Dopamine beta-hydroxylase inhibition in a patient with Wilson's disease and manic symptoms.
Herpes Simplex
3-Substituted adenines. In vitro enzyme inhibition and antiviral activity.
Herpes Zoster
Dopamine is taken up from the circulation by, and released from, local noradrenergic varicose axon terminals in zona glomerulosa of the rat: a neurochemical and immunocytochemical study.
In vivo voltammetric monitoring of noradrenaline release and catecholamine metabolism in the hypothalamic paraventricular nucleus.
Noradrenergic innervation of the hypothalamus of rhesus monkeys: distribution of dopamine-beta-hydroxylase immunoreactive fibers and quantitative analysis of varicosities in the paraventricular nucleus.
Huntington Disease
Serum dopamine-beta-hydroxylase activity in patients with Huntington's chorea and Parkinson's disease.
Hyperglycemia
Dietary protein and carbohydrate effects on blood parameters related to stress in cat.
Effect of diabetic hyperglycemia and other sugars on plasma dopamine-beta-hydroxylase activity.
Inhibitory mechanisms of insulin secretion associated with hypothermic open-heart surgery.
Hyperkinesis
Locomotor stimulation by L-dopa: relative importance of noradrenaline receptor activation.
The hyperkinetic syndrome following long-term haloperidol treatment: involvement of dopamine and noradrenaline.
Hyperprolactinemia
Effects of ovariectomy and hyperprolactinemia on tyrosine hydroxylase and dopamine-beta-hydroxylase activity in various limbic and hypothalamic structures.
Evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia.
Hypersensitivity
A Tropomyosine Receptor Kinase Inhibitor Blocks Spinal Neuroplasticity Essential for the Anti-Hypersensitivity Effects of Gabapentin and Clonidine in Rats With Peripheral Nerve Injury.
Hypertension
A defective beta-hydroxylation of dopamine may precede the full development of hypertension in spontaneously hypertensive rats.
Acute effect of labetalol on blood pressure in relation to the sympathetic nervous system and plasma renin activity.
Aromatic L-amino acid decarboxylase, dopamine beta-hydroxylase, monoamine oxidase, malondialdehyde, and acid phosphatase in rat brain capillaries and kidney glomeruli in experimental hypertension.
Association of dopamine beta-hydroxylase polymorphism with hypertension through interaction with fasting plasma glucose in Japanese.
Autonomic function in hypertension. Are there racial differences?
Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats.
Cerebrospinal fluid and plasma dopamine-beta-hydroxylase activity in human hypertension.
Depression, hypertension, and serum dopamine-beta-hydroxylase activity.
Disulfiram-Induced De Novo Convulsions without Alcohol Challenge: Case Series and Review of Literature.
Dopamine beta-hydroxylase distribution in density gradients: physiological and artefactual implications.
Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency.
Dopamine beta-hydroxylase release during hypertension from sympathetic nervous overactivity in man.
Dopamine-beta-hydroxylase after treatment with beta-blockers in hypertension.
Dopamine-beta-hydroxylase and plasma renin activity in twenty hypertensive subjects.
Dopamine-beta-hydroxylase in hypertension.
Effects of various stimuli on plasma dopamine beta-hydroxylase activity in essential hypertension with respect to aging and hypertension severity index.
Elevated plasma dopamine beta hydroxylase activity in rats with neurogenic hypertension.
Hemofiltration for the treatment of hypertensions associated with end-stage renal failure.
Hypertension: its effect on the stimulated release of dopamine-beta-hydroxylase in the rat.
Low response of serum dopamine beta-hydroxylase to stimuli in primary hypertension. Decreased DbetaH response in hypertension.
Mechanism of suppressed renin-angiotensin system in spontaneously hypertensive rat (SHR).
Metabolic and endocrine changes in spinal cord injury: II (section 1). Consequences of partial decentralization of the autonomic nervous system.
Norepinephrine-synthesizing enzymes in brain, adrenals and peripheral sympathetic nerves of spontaneously hypertensive rats.
Pathogenesis of spontaneous hypertension as a model for essential hypertension.
Plasma dopamine beta-hydroxylase: a possible aid in the study and evaluation of hypertension.
Plasma dopamine-beta-hydroxylase activity in oral contraceptive hypertension.
Plasma noradrenaline concentrations in experimental renovascular hypertension in the rat.
Proceedings: Serum dopamine-beta-hydroxylase: a possible aid in the evaluation of hypertension.
Racial differences of parameters associated with blood pressure levels in children--the Bogalusa heart study.
Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension.
Regional changes in the activities of aminergic biosynthetic enzymes in the brains of hypertensive rats.
Relationship between serum dopamine-beta-hydroxylase activity, catecholamine metabolism, and hemodynamic changes during paroxysmal hypertension in quadriplegia.
Relationships between blood pressure and plasma renin, aldosterone and dopamine-beta--hydroxylase in the elderly. Studies in patients over 70 years of age.
Results of treatment of hypertension after renal transplantation: effects of converting enzyme inhibitor, angiotensin II analog, beta-blockade, and dopamine beta-hydroxylase inhibitor.
Serum dopamine-beta-hydroxylase activity in essential hypertension and in chronic renal failure with hypertension.
Serum dopamine-beta-hydroxylase as an indicator of sympathetic activity and primary hypertension.
Serum dopamine-beta-hydroxylase during development of immobilization-induced hypertension.
Serum dopamine-beta-hydroxylase: a possible aid in the evaluation of hypertension.
Systemic hypertension associated with coronary artery bypass surgery. Predisposing factors, hemodynamic characteristics, humoral profile, and treatment.
The effects of therapy for mild hypertension on circulating level of dopamine beta-hydroxylase.
The evaluation of plasma dopamine beta-hydroxylase activity in essential and secondary hypertension.
The role of the sympathetic nervous system in oestrogen-induced hypertension in rats.
Urinary kallikrein excretion and plasma DBH activity in hypertension.
[Changes in plasma dopamine beta-hydroxylase activity in patients with hypertension treated with clofelin]
[Changes in serum dopamine beta-hydroxylase activities and hypertension during excision of adrenal tumor]
[Degree of dopamine beta-hydroxylase activity of blood plasma in hypertension]
[Immobilization stress and its significance for psychosomatic medicine]
[Plasma dopamine beta-hydroxylase activity in hypertension treated with adrenergic beta receptor blockaders]
[Serum dopamine-beta-hydroxylase activity in endocrine disease and hypertension (author's transl)]
[Study of the plasma activity of dopamine-beta-hydroxylase in patients with arterial hypertension]
[The sympathetic nervous system and dopamine-beta-hydroxylase in hypertension]
[The sympathetic nervous system inhibition in the antihypertensive effect of beta-blockers (author's transl)]
Hypertension, Portal
Alteration of blood dopamine-beta-hydroxylase activity in patients with intrahepatic portal hypertension.
Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.
[Alterations of blood dopamine-beta-hydroxylase activity in patients with intrahepatic portal hypertension]
Hypertension, Pregnancy-Induced
Plasma dopamine beta-hydroxylase activity in pregnancy-induced hypertension.
The study of levels of norepinephrine and dopamine-beta-hydroxylase in patients with pregnancy-induced hypertension.
[Activity of plasma dopamine-beta-hydroxylase in newborn infants. Implication in prematurity, maternal pathology and growth]
Hypertension, Renovascular
Increased hypothalamic noradrenergic activity in one-kidney, one-clip renovascular hypertensive rats.
Hyperthyroidism
Decreased serum dopamine-beta-hydroxylase in hyperthyroidism.
Effect of beta-adrenergic blockade on plasma dopamine-beta-hydroxylase activity and triiodothyronine in hyperthyroidism.
Evolution of plasma dopamine-beta-hydroxylase in hypo- and hyperthyroid young rats.
[Plasma dopamine beta hydroxylase (D beta H) changes in hyperthyroidism]
Hypertrophy, Left Ventricular
Diminished neuropeptide Y and dopamine beta-hydroxylase immunoreactivity in a guinea pig model of left ventricular hypertrophy.
Hypoglycemia
Dopamine-beta-hydroxylase deficiency in humans.
Effects of chemical sympathectomy on the increases in plasma catecholamines and dopamine-beta-hydroxylase induced by forced immobilization and insulin-induced hypoglycemia: origin and fate of plasma dopamine-beta-hydroxylase.
Elevation of plasma dopamine-beta-hydroxylase activity during insulin-induced hypoglycemia in man.
Histidyl-proline diketopiperazine cyclo (His-Pro): identification and characterization in rat pancreatic islets.
Serum dopamine-beta-hydroxylase activity does not reflect sympathetic activation during hypoglycemia.
Sex-specific acclimation of A2 noradrenergic neuron dopamine-?-hydroxylase and estrogen receptor variant protein and 5'-AMP-Activated protein kinase reactivity to recurring hypoglycemia in rat.
Unimpaired beta adrenergic responses during prazosin administration.
Hypotension
Adrenal origin of the increase in plasma dopamine beta-hydroxylase and catecholamines induced by hemorrhagic hypotension in dogs.
Contribution of adrenal medulla, spleen and lymph, to the plasma levels of dopamine beta-hydroxylase and catecholamines induced by hemorrhagic hypotension in dogs.
Dopamine-beta-hydroxylase deficiency in humans.
Metabolic and endocrine changes in spinal cord injury: II (section 1). Consequences of partial decentralization of the autonomic nervous system.
Plasma renin and serum dopamine-beta-hydroxylase during orthostatic hypotension in quadriplegic man.
Relationship to survival of catecholamine levels and dopamine-beta-hydroxylase activity in experimental haemorrhagic shock.
Serum dopamine beta-hydroxylase in cardiovascular diseases.
The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine.
Hypotension, Orthostatic
Catecholamine enzymes in the degenerative neurological disease idiopathic orthostatic hypotension.
Clinical, autonomic and therapeutic observations in two siblings with postural hypotension and sympathetic failure due to an inability to synthesize noradrenaline from dopamine because of a deficiency of dopamine beta hydroxylase.
d,l-threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency.
Dopamine beta-hydroxylase deficiency.
Dopamine-beta-hydroxylase deficiency in humans.
Droxidopa for Hypotension of Different Etiologies: Two Case Reports.
Droxidopa for Symptomatic Neurogenic Hypotension.
Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in dopamine-beta-hydroxylase deficiency.
Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency.
Genetic determinants of dopaminergic activity: potential role in blood pressure regulation.
Patterns of plasma levels of catechols in neurogenic orthostatic hypotension.
Plasma renin and serum dopamine-beta-hydroxylase during orthostatic hypotension in quadriplegic man.
Postural hypotension enhanced by exercise in patients with chronic autonomic failure.
The discovery of the pressor effect of DOPS and its blunting by decarboxylase inhibitors.
The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine.
[From gene to disease; dopamine-beta-hydroxylase deficiency and orthostatic hypotension]
[The most common dysautonomias]
Hypothyroidism
Developmental pattern of dopamine beta-hydroxylase induction in the adrenals of the rat. Influence of neonatal hypothyroidism.
Evolution of plasma dopamine-beta-hydroxylase in hypo- and hyperthyroid young rats.
Influence of hypothyroidism on adrenal dopamine-beta-hydroxylase in the developing rat.
Tyrosine hydroxylase and dopamine beta-hydroxylase inductions evoked by reserpine in the superior cervical ganglion of developing eu- and hypothyroid rats.
Infections
Bovine dopamine beta-hydroxylase cDNA. Complete coding sequence and expression in mammalian cells with vaccinia virus vector.
QseC mediates Salmonella enterica serovar typhimurium virulence in vitro and in vivo.
Inflammatory Bowel Diseases
A single nucleotide polymorphism in dopamine beta hydroxylase (rs6271(C>T)) is over-represented in inflammatory bowel disease patients and reduces circulating enzyme.
Intracranial Aneurysm
Serum dopamine beta-hydroxylase activity following subarachnoid hemorrhage in man.
Kidney Failure, Chronic
Dopamine-beta-hydroxylase activity and catecholamine levels in the plasma of patients with renal failure.
Hemofiltration for the treatment of hypertensions associated with end-stage renal failure.
Plasma catecholamines and dopamine-beta-hydroxylase activity in chronic renal failure.
Plasma norepinephrine and dopamine-beta-hydroxylase activity in chronic renal failure.
Serum dopamine-beta-hydroxylase activity in essential hypertension and in chronic renal failure with hypertension.
[The function of the sympathetic nervous system determined by humoral factors in the maintenance hemodialysis patients]
Lesch-Nyhan Syndrome
Lesch-Nyhan syndrome: low dopamine-beta-hydroxylase activity and diminished sympathetic response to stress and posture.
Leukemia
Comparative mapping of mouse chromosome 2 and human chromosome 9q: the genes for gelsolin and dopamine beta-hydroxylase map to mouse chromosome 2.
Letter: Serum dopamine-beta-hydroxylase activity in patients with leukemia and in patients with hepatoma.
Liver Failure
Concentrations of 3,4-dihydroxyphenylalanine and catecholamines and metabolites in brain in an anhepatic model of hepatic encephalopathy.
Lordosis
Noradrenergic transmission and female sexual behavior of guinea pigs.
Lymphocytic Choriomeningitis
A structural basis for CD8+ T cell-dependent recognition of non-homologous peptide ligands: implications for molecular mimicry in autoreactivity.
Menkes Kinky Hair Syndrome
Catecholamine Metabolites Affected by the Copper-Dependent Enzyme Dopamine-Beta-Hydroxylase Provide Sensitive Biomarkers for Early Diagnosis of Menkes Disease and Viral-Mediated ATP7A Gene Therapy.
Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency.
Genomic organization of ATOX1, a human copper chaperone.
Neurochemical and immunocytochemical studies of catecholamine system in the brindled mouse.
Plasma and cerebrospinal fluid neurochemical pattern in Menkes disease.
Relative Efficiencies of Plasma Catechol Levels and Ratios for Neonatal Diagnosis of Menkes Disease.
Screening for Menkes disease using the urine HVA/VMA ratio.
Migraine Disorders
A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes.
Analysis of dopamine beta hydroxylase gene polymorphisms in migraine.
Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura.
Association between migraine and a functional polymorphism at the dopamine beta-hydroxylase locus.
Cardiovascular and biochemical assessment in migraine patients submitted to tilt test.
Dopamine-beta-hydroxylase 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine.
Dopamine: what's new in migraine?
Effects of biofeedback upon suppression of migraine symptoms and plasma dopamine-beta-hydroxylase activity.
Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine.
Evidence for an altered dopamine beta-hydroxylase activity in migraine and tension-type headache.
Identification of a Novel ANKK1 and Other Dopaminergic (DRD2 and DBH) Gene Variants in Migraine Susceptibility.
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study.
New genetic evidence for involvement of the dopamine system in migraine with aura.
Serum dopamine beta-hydroxylase activity in menstrual migraine.
Serum dopamine-beta-hydroxylase activity in migraine.
[Cerebral vascular changes and plasma dopamine beta-hydroxylase activity in migraine]
Migraine with Aura
Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura.
New genetic evidence for involvement of the dopamine system in migraine with aura.
Mitral Valve Stenosis
Pattern of distribution of dopamine-beta-hydroxylase activity in normal subjects and in patients with mitral stenosis or left to right shunts.
Movement Disorders
[Serum dopamine-beta-hydroxylase, glutamic acid decarboxylase and 1-aromatic amino acid decarboxylase in involuntary movement disorders (author's transl)]
Multiple Sclerosis
Platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in patients with multiple sclerosis.
Multiple System Atrophy
Bilateral Horner's syndrome: detection and occurrence.
Droxidopa for Symptomatic Neurogenic Hypotension.
Patterns of plasma levels of catechols in neurogenic orthostatic hypotension.
The discovery of the pressor effect of DOPS and its blunting by decarboxylase inhibitors.
The pathophysiology and diagnosis of orthostatic hypotension.
Variations in the dopamine beta-hydroxylase gene are not associated with the autonomic disorders, pure autonomic failure, or multiple system atrophy.
Muscle Spasticity
The influence of noradrenergic blockade on vasospasm and the quantity of cerebral dopamine beta-hydroxylase following subarachnoid haemorrhage in rabbits.
Mydriasis
CNS alpha 2-adrenoceptor induced mydriasis in conscious rats.
Myocardial Infarction
Dopamine-beta-hydroxylase activity after acute myocardial infarction.
Dopamine-beta-hydroxylase activity in serum following acute myocardial infarction: an evaluation of this parameter for routine use as an index of sympathetic activity.
Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock.
Segregation and linkage analyses of dopamine-beta-hydroxylase activity in a six-generation pedigree.
Serum dopamine beta-hydroxylase (DBH) activity in acute myocardial infarction.
Serum dopamine beta-hydroxylase activity in acute cardiac disease.
[Blood and urine catecholamine levels and dopamine beta-hydroxylase activity in the acute phase of myocardial infarction]
[Dopamine beta-hydroxylase activity in myocardial infarction]
[Relationship between catecholamines, dopamine beta hydroxylase and cyclic AMP in acute myocardial infarct]
Myocardial Ischemia
Serum dopamine beta-hydroxylase in cardiovascular diseases.
Nasal Polyps
Presence of neuropeptides in human nasal polyps.
Neoplasm Metastasis
[Treatment of carcinoid tumor with a long-acting somatostatin analog]
Neoplasms
A dopamine-secreting pheochromocytoma.
A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case.
Biochemical activity in the metastatic lesions of neuroblastoma.
Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomas.
Circulating dopamine-beta-hydroxylase (DbetaH) and catecholamines in a paediatric phaeochromocytoma.
Comparative study of plasma dopamine-beta-hydroxylase activities in noradrenaline-secreting and adrenaline-secreting phaeochromocytomae.
Diagnostic immunohistochemistry of neuroblastic tumors.
Growth of human pheochromocytomas in the anterior eye chamber of the rat. A histochemical study on amine and peptide content of pheochromocytoma tumour cells.
Human neuroblastoma in nude mice.
Immunohistochemical markers in (ganglio)neuroblastomas.
Multiple molecular forms of dopamine beta-hydroxylase in the C1300 mouse neuroblastoma tumor and in the serum of tumor-bearing mice.
Oncocytic adrenocortical neoplasms: a report of seven cases and review of the literature.
Plasma and tumor dopamine-beta-hydroxylase activity in patients with familial pheochromocytomas.
Plasma dopamine beta-hydroxylase in a noradrenalin-secreting pheochromocytoma.
Rat dopamine beta-hydroxylase: molecular cloning and characterization of the cDNA and regulation of the mRNA by reserpine.
The expression of PHOX2A, PHOX2B and of their target gene dopamine-beta-hydroxylase (DbetaH) is not modified by exposure to extremely-low-frequency electromagnetic field (ELF-EMF) in a human neuronal model.
[Changes in serum dopamine beta-hydroxylase activities and hypertension during excision of adrenal tumor]
[Dopamine beta hydroxylase (EC. 1.14.2.1) in the blood of mice with neuroblastoma (C1300). Relation to tumor growth]
[Dopamine beta-hydroxylase in tumors of sympathetic origin]
[Plasma dopamine-beta-hydroxylase activity in pheochromocytoma (author's transl)]
Nephrotic Syndrome
[Dopamine beta-hydroxylase activity in the plasma of children with steroid-sensitive nephrotic syndrome]
Nervous System Diseases
Dopamine beta-hydroxylase distribution in density gradients: physiological and artefactual implications.
Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.
Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension.
Neuroblastoma
A bifunctional genetic regulatory element of the rat dopamine beta-hydroxylase gene influences cell type specificity and second messenger-mediated transcription.
A neuroblastoma-selective suicide gene therapy approach using the tyrosine hydroxylase promoter.
A protein kinase C-activating phorbol ester enhances transcription of the human DBH gene through a cyclic AMP response element in SK-N-BE(2)C cells.
Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival.
Ciliary neurotrophic factor suppresses Phox2a in sympathetic neurons.
Combined measurements of plasma aromatic L-amino acid decarboxylase and DOPA as tumour markers in diagnosis and follow-up of neuroblastoma.
Concomitant elevation of tyrosine hydroxylase and dopamine beta-hydroxylase by cyclic AMP in cultured mouse neuroblastoma cells.
Cytokine suppression of dopamine-beta-hydroxylase by extracellular signal-regulated kinase-dependent and -independent pathways.
Dopamine-beta-hydroxylase activity in cholinergic neuroblastoma times glioma hybrid cells; increase of activity by N6,O2'-dibutyryl adenosine 3':5'-cyclic monophosphate.
Dopamine-beta-hydroxylase effectors in neuroblastoma.
Flow cytometry DNA ploidy analysis and catecholamine secretion profiles in neuroblastoma.
Immunohistochemical evidence for a plasma membrane localization of dopamine-beta-hydroxylase in C1300 mouse neuroblastoma [proccedings]
Immunohistochemical evidence for a plasma membrane localization of dopamine-beta-hydroxylase in the mouse neuroblastoma.
Immunohistochemical markers in (ganglio)neuroblastomas.
Induction of tyrosine hydroxylase and dopamine beta-hydroxylase in cultured mouse neuroblastoma by 8Br-cAMP. Involvement of RNA and protein synthesis.
Inhibitory effects of nitric oxide and nitrosative stress on dopamine-beta-hydroxylase.
Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
Localization of noradrenaline and dopamine-beta-hydroxylase in C1300 mouse neuroblastoma. A biochemical and electronmicroscopic study.
Multiple forms of human dopamine beta-hydroxylase in SH-SY5Y neuroblastoma cells.
Multiple molecular forms of dopamine beta-hydroxylase in the C1300 mouse neuroblastoma tumor and in the serum of tumor-bearing mice.
Pharmacogenomic analysis of mechanisms mediating ethanol regulation of dopamine beta-hydroxylase.
Plasma dopamine-beta-hydroxylase in neuroblastoma.
Plasma dopamine-beta-hydroxylase in the diagnosis of neuroblastoma.
Polyacrylamide gel electrophoresis of dopamine-beta-hydroxylase of the C1300 mouse neuroblastoma [proceedings]
Serial studies of serum dopamine-B-hydroxylase and urinary vanillylmandelic and homovanillic acids in neuroblastoma.
Serum dopamine beta hydroxylase in children with neuroblastoma.
Serum dopamine-beta-hydroxylase activity in neuroblastoma.
Stimulation of human DBH gene expression by prostaglandin E2 in human neuroblastoma SK-N-BE(2)C cells.
Transcriptional modulation of monoaminergic neurotransmission genes by the histone deacetylase inhibitor trichostatin A in neuroblastoma cells.
[Dopamine beta hydroxylase (EC. 1.14.2.1) in the blood of mice with neuroblastoma (C1300). Relation to tumor growth]
Neurocirculatory Asthenia
Serum dopamine beta-hydroxylase in cardiovascular diseases.
Obesity
Thermoregulatory and metabolic phenotypes of mice lacking noradrenaline and adrenaline.
[Serum dopamine beta-hydroxylase activity in obesity and during a two-week fasting period]
Obstetric Labor, Premature
[Activity of the adrenergic nervous system in the pathophysiology of pregnancy and labor. I. Dopamine beta-hydroxylase (DBH) activity in the plasma of women with physiological pregnancy, threatened and completed abortion and threatened and completed premature labor]
[Activity of the adrenergic nervous system in the pathophysiology of pregnancy and labor. II. Dopamine beta-hydroxylase activity in maternal plasma in physiological and premature labor]
Orthostatic Intolerance
Variations in the dopamine beta-hydroxylase gene are not associated with the autonomic disorders, pure autonomic failure, or multiple system atrophy.
Paraganglioma, Extra-Adrenal
Liquid-chromatographic determination of free and total 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol in urine.
Paraneoplastic Syndromes
Pupil abnormalities in selected autonomic neuropathies.
Parkinson Disease
A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease.
Association of Dopamine Beta-Hydroxylase (DBH) Polymorphisms with Susceptibility to Parkinson's Disease.
Association of Dopamine Beta-Hydroxylase Polymorphisms with Alzheimer's Disease, Parkinson's Disease and Schizophrenia: Evidence Based on Currently Available Loci.
Association of the rs1611115 polymorphism in DBH gene with Parkinson's disease: a meta-analysis.
CSF dopamine-beta-hydroxylase activity in Parkinson's disease.
Determination of D,L-threo-3,4-dihydroxyphenylserine and of the D- and L-enantiomers in human plasma and urine.
Dissociation of neuropeptide Y and somatostatin in Parkinson's disease.
Dopamine beta-hydroxylase -1021C>T association and Parkinson's disease.
Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency.
Droxidopa for Hypotension of Different Etiologies: Two Case Reports.
Plasma dopamine-beta-hydroxylase and erythrocyte acetylcholinesterase in a group of patients with Parkinson disease.
Role of polymorphisms in dopamine synthesis and metabolism genes and association of DBH haplotypes with Parkinson's disease among North Indians.
Serum dopamine-beta-hydroxylase activity in patients with Huntington's chorea and Parkinson's disease.
[Dopamine beta hydroxylase gene polymorphism and Parkinson's disease]
[Effect of bromocriptine on secretion of the enzyme dopamine-B-hydroxylase (DBH) in patients with Parkinson's disease]
[Pharmacologic approach to autonomic failure]
Parkinsonian Disorders
Delusional depression in Parkinson's disease.
Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency.
Increase in noradrenaline-synthesizing enzyme activity in medulla oblongata in Parkinson's disease.
Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain.
Serum dopamine-beta-hydroxylase in parkinsonism.
Peripheral Nervous System Diseases
Axonal transport of dopamine-beta-hydroxylase and acetylcholinesterase in human peripheral neuropathy.
Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism.
Pheochromocytoma
A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case.
Alterations in plasma dopamine-beta-hydroxylase and catecholamine concentrations during surgical removal of pheochromocytoma.
Autonomic hyperreflexia and its differentiation from pheochromocytoma.
Catecholamine-synthesizing enzymes and chromogranin proteins in drug-induced proliferative lesions of the rat adrenal medulla.
Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomas.
Comparison of dopamine beta-hydroxylase activity in normal rat adrenal medulla and rat pheochromocytoma cells.
Deficiency of dopamine-beta-hydroxylase. A new mechanism for normotensive pheochromocytomas.
Differential effect of membrane depolarization on levels of tyrosine hydroxylase and dopamine beta-hydroxylase mRNAs in PC12 pheochromocytoma cells.
Dopamine-beta-hydroxylase: structural comparisons of membrane-bound versus soluble forms from adrenal medulla and pheochromocytoma.
Effect of monensin on synthesis, post-translational processing, and secretion of dopamine beta-hydroxylase from PC12 pheochromocytoma cells.
Effects of PAMP on mRNAs coding for catecholamine-synthesizing enzymes in PC12 cells.
Exocytosis plays an important role in catecholamine secretion from human pheochromocytoma.
Expression of mRNA coding for four catecholamine-synthesizing enzymes in human adrenal pheochromocytomas.
Genes for catecholamine biosynthesis: cloning by expression and identification of the cDNA for rat dopamine beta-hydroxylase.
Human dopamine beta-hydroxylase gene: two mRNA types having different 3'-terminal regions are produced through alternative polyadenylation.
Human dopamine-beta-hydroxylase: comparison of the enzyme from plasma, adrenal medulla, and pheochromocytoma by radioimmunoassay.
Human pheochromocytoma dopamine-beta-hydroxylase: purification and molecular parameters of the tetramer.
In vitro translation of human pheochromocytoma messenger RNAs: characterization of tyrosine-hydroxylase and dopamine-beta-hydroxylase.
Laminar, tangential and regional organization of the noradrenergic innervation of monkey cortex: dopamine-beta-hydroxylase immunohistochemistry.
Liquid-chromatographic determination of free and total 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol in urine.
Mechanism of biosynthesis of soluble and membrane-bound forms of dopamine beta-hydroxylase in PC12 pheochromocytoma cells.
Nicotinic induction of preproenkephalin and tyrosine hydroxylase gene expression in butyrate-differentiated rat PC12 cells: a model for adaptation to gut-derived environmental signals.
Phenylethanolamine-N-methyltransferase activity determines the epinephrine concentration of pheochromocytomas.
Plasma and tumor dopamine-beta-hydroxylase activity in patients with familial pheochromocytomas.
Plasma dopamine beta-hydroxylase in a noradrenalin-secreting pheochromocytoma.
Purification and characterization of rat pheochromocytoma dopamine beta-hydroxylase.
Purification and immunochemical characterization of dopamine beta-hydroxylase from human pheochromocytoma.
Rapid, high-yield isolation of human chromogranin A from chromaffin granules of pheochromocytomas.
Rat dopamine beta-hydroxylase: molecular cloning and characterization of the cDNA and regulation of the mRNA by reserpine.
Regulation of the multiple forms of dopamine beta-hydroxylase by nerve growth factor, dexamethasone, and dibutyryl cyclic AMP in the PC12 pheochromocytoma cell line.
Secretory-granule dynamics visualized in vivo with a phogrin-green fluorescent protein chimaera.
Simultaneous evaluation of the catecholamine pathway and three opioid peptide-producing systems in human pheochromocytomas.
Soluble and membrane-bound forms of dopamine beta-hydroxylase are encoded by the same mRNA.
Studies on the interaction of dopamine beta-hydroxylase from various sources with phytohaemagglutinins.
Sulfation and constitutive secretion of dopamine beta-hydroxylase from rat pheochromocytoma (PC12) cells.
The primary structure of human dopamine-beta-hydroxylase: insights into the relationship between the soluble and the membrane-bound forms of the enzyme.
[Expression of mRNAs coding for catecholamine synthesizing enzymes in human adrenal pheochromocytoma]
[Plasma dopamine-beta-hydroxylase activity in pheochromocytoma (author's transl)]
Placenta Previa
Peripartum management of a patient with dopamine beta-hydroxylase deficiency, a rare congenital cause of dysautonomia.
Postural Orthostatic Tachycardia Syndrome
Dopamine-beta-hydroxylase in postural tachycardia syndrome.
Pre-Eclampsia
[Blood plasma dopamine beta-hydroxylase and monoamine oxidase activity in pregnancy toxemias]
Primary Dysautonomias
Peripartum management of a patient with dopamine beta-hydroxylase deficiency, a rare congenital cause of dysautonomia.
Pupil abnormalities in selected autonomic neuropathies.
The sympathetic skin response in peripheral autonomic failure--evaluation in pure failure, pure cholinergic dysautonomia and dopamine-beta-hydroxylase deficiency.
Pseudorabies
Noradrenergic axon terminals contact gastric preautonomic neurons in the paraventricular nucleus of the hypothalamus in rats.
Pure Autonomic Failure
Bilateral Horner's syndrome: detection and occurrence.
Classification of autonomic disorders.
Droxidopa for Hypotension of Different Etiologies: Two Case Reports.
Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.
Patterns of plasma levels of catechols in neurogenic orthostatic hypotension.
Postural hypotension enhanced by exercise in patients with chronic autonomic failure.
Pupil abnormalities in selected autonomic neuropathies.
The discovery of the pressor effect of DOPS and its blunting by decarboxylase inhibitors.
The influence of food on postural hypotension in three groups with chronic autonomic failure--clinical and therapeutic implications.
The pathophysiology and diagnosis of orthostatic hypotension.
Variations in the dopamine beta-hydroxylase gene are not associated with the autonomic disorders, pure autonomic failure, or multiple system atrophy.
[Pharmacologic approach to autonomic failure]
Quadriplegia
Relationship between serum dopamine-beta-hydroxylase activity, catecholamine metabolism, and hemodynamic changes during paroxysmal hypertension in quadriplegia.
Serum dopamine beta-hydroxylase (D beta H) levels during tilting in patients with spinal cord injuries.
[Etiological aspects of orthostatic hypotension]
Rabies
Afferent and efferent connections of C1 cells with spinal cord or hypothalamic projections in mice.
Renal Insufficiency
Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency.
Dopamine-beta-hydroxylase activity and catecholamine levels in the plasma of patients with renal failure.
Norepinephrine clearance, chromogranin A and dopamine beta hydroxylase in renal failure.
[Dopamine beta-hydroxylase activity in the plasma of patients with chronic decompensated renal failure]
Seizures
Can disulfiram (Antabuse) be safely co-administered with the monoamine oxidase inhibitor (MAOI) antidepressants? Despite the ability of the major metabolite of disulfiram (diethyldithiocarbamate) to inhibit the enzyme dopamine beta-hydroxylase and a report of the induction in rats of central motor disturbances, convulsions, and death following the co-administration of tranylcypromine, there appears to be surprisingly little in the literature that directly addresses this question.
Disulfiram-Induced De Novo Convulsions without Alcohol Challenge: Case Series and Review of Literature.
Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures.
Genetic comparison of seizure control by norepinephrine and neuropeptide Y.
Modulation of hippocampal excitability and seizures by galanin.
Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli.
Reduced anticonvulsant efficacy of valproic acid in dopamine beta-hydroxylase knockout mice.
[Combination of DAT and DBH gene polymorphisms with a family history of alcohol use disorders increases the risk of withdrawal seizures and delirium tremens during alcohol withdrawal in alcohol-dependent men].
Sepsis
Increased gut-derived norepinephrine release in sepsis: up-regulation of intestinal tyrosine hydroxylase.
Shock, Cardiogenic
Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock.
Shy-Drager Syndrome
Determination of D,L-threo-3,4-dihydroxyphenylserine and of the D- and L-enantiomers in human plasma and urine.
Sleep Deprivation
Proceedings: Changes in cyclic AMP and dopamine-beta-hydroxylase during sleep deprivation.
Spasm
Effect of dopamine-beta-hydroxylase inhibition on cerebral vasospasm in the cat.
Spinal Cord Injuries
Co-localization of substance P and dopamine beta-hydroxylase with growth-associated protein-43 is lost caudal to a spinal cord transection.
Dopamine beta-hydroxylase release during hypertension from sympathetic nervous overactivity in man.
Dopamine-beta-hydroxylase in experimental spinal cord injury.
Serum dopamine beta-hydroxylase (D beta H) levels during tilting in patients with spinal cord injuries.
Spinocerebellar Ataxias
Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures.
Starvation
[The effect of one-time and repeated starvation on dopamine beta-hydroxylase serum activity in rats of various ages]
Stroke
Reversible changes in the activities of tyrosine hydroxylase and dopamine-beta-hydroxylase in neurons of the nucleus locus coeruleus after experimental stroke.
Serum dopamine-beta-hydroxylase activity in acute stroke.
[Changes in plasma dopamine-beta-hydroxylase activity in acute cerebrovascular accidents (author's transl)]
Subarachnoid Hemorrhage
Correspondence between the time course of cerebral vasospasm and the level of cerebral dopamine-beta-hydroxylase in rabbits.
Serum dopamine beta-hydroxylase activity following subarachnoid hemorrhage in man.
[Changes in plasma dopamine-beta-hydroxylase activity in patients with acute subarachnoid hemorrhage (author's transl)]
[Dopamine beta-hydroxylase activity after subarachnoid hemorrhage]
[Level of dopamine beta-hydroxylase activity in subarachnoid hemorrhage treated conservatively and surgically]
Syncope
Dopamine beta-hydroxylase deficiency.
Tachycardia
Adrenergic mechanisms in postvagal tachycardia.
Dopamine-beta-hydroxylase in postural tachycardia syndrome.
Mechanism of the tachycardia following systemic alpha-methyldopa administration in conscious rats.
Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor.
Tardive Dyskinesia
Clonidine trial in tardive dyskinesia. Therapeutic response, MHPG, and plasma DBH.
Enzyme studies in tardive dyskinesia. I. One-year biochemical follow-up.
Enzyme studies in tardive dyskinesia. II. Familial aspects.
Enzyme studies in tardive dyskinesia. III. Noradrenergic hyperactivity in a subgroup of dyskinetic patients.
Impaired noradrenergic transmission in schizophrenia?
Neurobiological characterization of bipolar affective disorders : a focus on tardive dyskinesia and soft neurological signs in relation to serum dopamine Beta hydroxylase activity.
Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma dopamine-beta-hydroxylase.
Platelet monoamine oxidase and plasma dopamine beta-hydroxylase in tardive dyskinesia.
Serum dopamine beta hydroxylase activity and tardive dyskinesia.
Tension-Type Headache
Evidence for an altered dopamine beta-hydroxylase activity in migraine and tension-type headache.
Tetanus
Dual properties of cultured retinoblastoma cells: immunohistochemical characterization of neuronal and glial markers.
Thrombosis
Bilateral Horner's syndrome: detection and occurrence.
Thyroid Crisis
[Proceedings: Serum dopamine-beta-hydroxylase activity. 3. A case of thyroid crisis]
Thyroid Diseases
[Proceedings: Serum dopamine beta hydroxylase activity. 2. Evaluation of thyroid diseases]
Torticollis
Plasma dopamine-beta-hydroxylase activity in spasmodic torticollis. A sibship study.
Tourette Syndrome
Analysis of the dopamine beta hydroxylase gene in Gilles de la Tourette syndrome.
Enzyme activity in Tourette's syndrome.
Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1.
The genetic susceptibility to Gilles de la Tourette syndrome in a large multiple affected British kindred: linkage analysis excludes a role for the genes coding for dopamine D1, D2, D3, D4, D5 receptors, dopamine beta hydroxylase, tyrosinase, and tyrosine hydroxylase.
Tremor
Lithium treatment during alcoholic withdrawal.
[Dopamine beta hydroxylase. Value and limits of its study in neurology]
Tuberculosis, Pulmonary
Sympathetic nervous systems in chronic hypoxic states from pulmonary tuberculosis: a clinical study on plasma norepinephrine and cyclic AMP levels.
Tuberous Sclerosis
Identification of markers flanking the tuberous sclerosis locus on chromosome 9 (TSC1).
Uremia
Plasma dopamine-beta-hydroxylase in uremia--increase in enzyme activity after renal transplantation.
Urinary Retention
The innervation of the human prostate gland--the changes associated with benign enlargement.
Vaccinia
3-Substituted adenines. In vitro enzyme inhibition and antiviral activity.
Bovine dopamine beta-hydroxylase cDNA. Complete coding sequence and expression in mammalian cells with vaccinia virus vector.
Expression of human dopamine beta-hydroxylase in mammalian cells infected by recombinant vaccinia virus. Mechanisms for membrane attachment.
Vascular Diseases
Sympathetic nervous system-targeted neuropeptide Y overexpression in mice enhances neointimal formation in response to vascular injury.
Vasospasm, Intracranial
Correspondence between the time course of cerebral vasospasm and the level of cerebral dopamine-beta-hydroxylase in rabbits.
Effect of dopamine-beta-hydroxylase inhibition on cerebral vasospasm in the cat.
Ventricular Dysfunction, Left
Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.